Market research
CAPLIPOINT.NSE Caplin Point Laboratories Limited
NSE INR Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 190B
- P/E ratio
- 29.32
- Analyst target
- 2765
- Dividend yield
- 0.0%
- Beta
- 0.37
Community
Investor discussion
1 comment
Sign in to join the CAPLIPOINT.NSE discussion.
5 years, 5 months ago
Caplin Point Laboratories Limited is currently in a long term uptrend where the price is trading 29.7% above its 200 day moving average.
From a valuation standpoint, the stock is 26.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.5.
Caplin Point Laboratories Limited's total revenue rose by 20.2% to $3B since the same quarter in the previous year.
Its net income has increased by 10.1% to $645M since the same quarter in the previous year.
Finally, its free cash flow grew by 286.9% to $2B since the same quarter in the previous year.
Based on the above factors, Caplin Point Laboratories Limited gets an overall score of 5/5.